Delivery Order SPE2DB20D1109-SPE2DB25FP27Q
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of a pediatric intravenous medication, Infuvite Pediatric Vial 5ML, with a ceiling value of $4,808.40 and a period of performance through November 2024. As the prime contractor, Amerisourcebergen is responsible for providing...
- This federal contract award, valued at $2,529.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of INFUVITE PEDIATRIC VIAL 5ML medical supplies, with a completion date of March 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,499.73 firm fixed-price delivery order is for the supply of Infuvite Adult Vial 10ML, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,659.19 firm fixed-price delivery order is for the supply of INFUVITE ADULT VIAL 10ML medical products, with a performance period ending on May 16, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,999.46 firm fixed-price delivery order is for the supply of 4568250414 - INFUVITE ADULT VIAL 10ML, with a performance period through May 15, 2025. The contract is not set-aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,126.15 Firm Fixed Price delivery order contract is for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a firm fixed price of $3,084.98 and a completion date of July 2, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides...
- This federal contract award, valued at $15,191.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a performance period extending through October 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award, valued at $19,198.79, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a period of performance through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a $5,876.47 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT VIAL 10ML medical supplies, with a period of performance through July 1, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP27QDelivery Order
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $1,399.72 for the supply of INFUVITE PEDIATRIC VIAL 5ML pharmaceutical products. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceutical products, medical supplies, and healthcare commodities to the military and veteran healthcare systems. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies through multiple delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/23/25 |